ホーム > 医療人の育成 > 専攻医(レジデント・専門修練医)募集について > 各部門のカリキュラム > 生活習慣病部門 > 生活習慣病部門(高血圧・腎臓科) 研究業績

生活習慣病部門(高血圧・腎臓科) 研究業績

印刷用PDF


研究業績

最近10年間のレジデント・専門修練医が筆頭著者の論文リスト

  1. Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y, Kangawa K. Impact of decreased serum albumin levels on acute kidney injury in patients with acute decompensated heart failure: a potential association of atrial natriuretic peptide. Heart Vessels. 2017 Feb 7. doi: 10.1007/s00380-017-0954-y. [Epub ahead of print] PubMed PMID: 28176004.
  2. Ohta Y, Ishizuka A, Arima H, Hayashi S, Iwashima Y, Kishida M, Yoshihara F, Nakamura S, Kawano Y. Effective uric acid-lowering treatment for hypertensive patients with hyperuricemia. Hypertens Res. 2017;40:259-263.
  3. Ohta Y, Kawano Y, Hayashi S, Iwashima Y, Yoshihara F, Nakamura S. Effects of cigarette smoking on ambulatory blood pressure, heart rate, and heart rate variability in treated hypertensive patients. Clin Exp Hypertens. 2016;38:510-513.
  4. Ohta Y, Iwayama K, Suzuki H, Sakata S, Hayashi S, Iwashima Y, Takata A, Kawano Y. Salt intake and eating habits of school-aged children. Hypertens Res. 2016 ;39:812-817.
  5. Ohta Y, Ohta K, Ishizuka A, Hayashi S, Kishida M, Iwashima Y, Yoshihara F, Nakamura S, Kawano Y. Trends in the awareness of salt restriction and actual salt intake in hypertensive patients at a hypertension clinic and general clinic: A one-year follow-up study. Clin Exp Hypertens. 2015;37(6):454-8. doi: 10.3109/10641963.2015.1057835. PubMed PMID: 26395951.
  6. Ohta Y, Ishizuka A, Hayashi S, Iwashima Y, Kishida M, Yoshihara F, Nakamura S, Kawano Y. Effects of a selective aldosterone blocker and thiazide-type diuretic on blood pressure and organ damage in hypertensive patients. Clin Exp Hypertens. 2015;37:569-573.
  7. Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y. Risk Stratification of Acute Kidney Injury Using the Blood Urea Nitrogen/Creatinine Ratio in Patients With Acute Decompensated Heart Failure. Circ J. 2015;79:1520-1525.
  8. Ohta Y, Ohta K, Ishizuka A, Hayashi S, Kishida M, Iwashima Y, Yoshihara F, Nakamura S, Kawano Y. Awareness of salt restriction and actual salt intake in hypertensive patients at a hypertension clinic and general clinic. Clin Exp Hypertens. 2015;37:172-175.
  9. Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y. Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure. Heart Vessels. 2016 Jan;31(1):60-5. doi: 10.1007/s00380-014-0572-x. Epub 2014 Aug 24. PubMed PMID: 25150587.
  10. Ohta Y, Iwashima Y, Hayashi S, Yoshihara F, Nakamura S, Kamide K, Horio T, Kawano Y. Trend of office and home blood pressure control in treated hypertensive patients: changes in antihypertensive medication and salt intake. Clin Exp Hypertens. 2014;36:103-107.
  11. Yamasaki T, Iwashima Y, Jesmin S, Ohta Y, Kusunoki H, Hayashi S, Horio T, Kawano Y. Comparison of efficacy of intensive versus mild pitavastatin therapy on lipid and inflammation biomarkers in hypertensive patients with dyslipidemia. PLoS One. 2014;9:e89057.
  12. Ohta Y, Kawano Y, Iwashima Y, Hayashi S, Yoshihara F, Matayoshi T, Takiuchi S, Kamide K, Nakamura S, Horio T. Control of home blood pressure with an amlodipine- or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: the HOSP substudy. Clin Exp Hypertens. 2013;35:279-284.
  13. Ohta Y, Kawano Y, Iwashima Y, Hayashi S, Yoshihara F, Nakamura S. Effect of bezafibrate on office, home and ambulatory blood pressure in hypertensive patients with dyslipidemia. J Hum Hypertens. 2013;27:417-420.
  14. Doi Y, Iwashima Y, Yoshihara F, Kamide K, Takata H, Fujii T, Kubota Y, Nakamura S, Horio T, Kawano Y. Association of renal resistive index with target organ damage in essential hypertension. Am J Hypertens. 2012;25:1292-1298.
  15. Doi Y, Iwashima Y, Yoshihara F, Kamide K, Hayashi S, Kubota Y, Nakamura S, Horio T, Kawano Y. Renal resistive index and cardiovascular and renal outcomes in essential hypertension. Hypertension. 2012;60:770-777.
  16. Niizuma S, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y. Kidney function and histological damage in autopsy subjects with myocardial infarction. Ren Fail. 2011;33(9):847-52. doi: 10.3109/0886022X.2011.605531. Epub 2011 Aug 8. PubMed PMID: 21823900.
  17. Suzuki C, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y. Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease. Ther Apher Dial. 2011;15:51-57.
  18. Nishida H, Horio T, Suzuki Y, Iwashima Y, Tokudome T, Yoshihara F, Nakamura S, Kawano Y. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein. Cytokine. 2011;53:342-346.
  19. Miwa Y, Kamide K, Takiuchi S, Yoshii M, Horio T, Tanaka C, Banno M, Miyata T, Kawano Y. Association of PLA2G7 polymorphisms with carotid atherosclerosis in hypertensive Japanese. Hypertens Res. 2009;32:1112-1118.
  20. Niizuma S, Takiuchi S, Okada S, Horio T, Kamide K, Nakata H, Yoshihara F, Nakamura S, Kawano Y, Nakahama H, Iwanaga Y, Nakatani S. Decreased coronary flow reserve in haemodialysis patients. Nephrol Dial Transplant. 2008;23:2324-2328.
  21. Nishida H, Horio T, Suzuki Y, Iwashima Y, Kamide K, Kangawa K, Kawano Y. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin. Peptides. 2008;29:599-605.
  22. Matayoshi T, Kamide K, Takiuchi S, Horio T, Yoshihara F, Nakamura S, Nakahama H, Kawano Y. Relationship between insulin resistance and the renin-angiotensin system: analysis for patients with essential and renovascular hypertension. Clin Exp Hypertens. 2007;29:479-487.
  23. Matayoshi T, Kato T, Nakahama H, Nakata H, Yoshihara F, Kamide K, Horio T, Nakamura S, Kawano Y. Brain natriuretic peptide in hemodialysis patients: predictive value for hemodynamic change during hemodialysis and cardiac function. Am J Nephrol. 2008;28:122-127.
  24. Yasuda H, Kamide K, Takiuchi S, Matayoshi T, Hanada H, Kada A, Yang J, Miwa Y, Yoshii M, Horio T, Yoshihara F, Nakamura S, Nakahama H, Tei C, Miyata T, Kawano Y. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension. J Hum Hypertens. 2007 Nov;21(11):883-92. Epub 2007 May 24. PubMed PMID: 17525706.
  25. Tomiyama M, Horio T, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension. J Hum Hypertens. 2007;21:212-219.

最終更新日 2017年05月31日

ページ上部へ